Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
estradiol valerate + norgestrel
- Development stage
- Phase 3
- Lead developer
- Bayer
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Estradiol valerate + norgestrel is a combination hormone replacement therapy (HRT) medication containing two female sex hormones: estradiol valerate (an estrogen) and norgestrel (a progestogen). The estradiol component is equivalent to the natural hormone and possesses the same properties, while norgestrel has an effect similar to the natural corpus luteum hormone progesterone. This combination is primarily used for hormone replacement therapy in menopausal women to help restore hormonal balance after the ovaries cease producing these hormones naturally. The medication is typically supplied as a sequential regimen with white tablets containing only estradiol valerate (2 mg) followed by light brown tablets containing both estradiol valerate (2 mg) and norgestrel (0.5 mg).
- Brand names
- ProgylutonCyclo-Progynova
- Other names
- estradiol valerate and norgestrelestradiol valerate/norgestrel
02
Targets
ESR1 (ERα)ESR2 (ERβ)GPER1 (G protein-coupled estrogen receptor 1)PR (Progesterone receptor)SHBG (Sex hormone-binding globulin)
Beyond the preview
Go deeper on estradiol valerate + norgestrel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on estradiol valerate + norgestrel.